Inhibition of Notch signaling may cause growth inhibition of GSCs [44], which we believed was a possible mechanism underlying Vastatin’s anti-glioma effect and distinguished Vastatin from traditional antiangiogenic agents. Here, COL8A1 is linked to glioma.